Tech Company Financing Transactions
VG Life Sciences Funding Round
VG Life Sciences, based in South Pasadena, scored $2.2 million in investment from MedBridge Venture Fund.
Transaction Overview
Company Name
Announced On
10/4/2013
Transaction Type
Venture Equity
Amount
$2,235,000
Round
Undisclosed
Investors
Proceeds Purpose
This new funding will enable VG Life Sciences to begin and complete many key milestones outlined in the Company's July Investor Letter and meet short term capital needs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
P.O. Box 1020
South Pasadena, CA 91031
USA
South Pasadena, CA 91031
USA
Phone
Website
Email Address
Overview
VG Life Sciences Inc. is a drug discovery and development company researching two core technologies: Targeted Peptides and Metabolic Disruption.The Company is researching the use of these technologies in the treatment of cancer, infectious disease, and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Haig Keledjian
Chief Scientific Officer
Karen Newell-Rogers
Browse more venture capital transactions:
Prev: 10/4/2013: Netskope venture capital transaction
Next: 10/4/2013: eTouches venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs